☆ 4.7 Article

Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma

BIOMEDICINE & PHARMACOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Oncology

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma

Ziyang Feng et al.

Summary: This study investigates the role of AMICA1 in lung adenocarcinoma (LUAD) using bioinformatic analysis and in vitro experiments. The results suggest that AMICA1 may serve as a diagnostic and prognostic biomarker for LUAD. It also plays a significant role in suppressing the proliferation of LUAD cells and is associated with immune cell infiltration. Furthermore, the study suggests that the cGAS-STING signaling pathway is important in this process.

CANCER CELL INTERNATIONAL (2022)

添加到收藏夹

Article Oncology

Non-Small Cell Lung Cancer, Version 3.2022

David S. Ettinger et al.

Summary: This passage introduces the recommended management for non-small cell lung cancer (NSCLC) in the NCCN Clinical Practice Guidelines, with a focus on targeted therapies for patients with metastatic NSCLC and actionable mutations.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

添加到收藏夹

Article Medicine, General & Internal

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach

Xiangyu Li et al.

Summary: In this study, a systematic approach was proposed to reposition drugs for the treatment of clear cell renal cell carcinoma (ccRCC). Using gene co-expression network analysis and drug-perturbed signature profiles, potential drug targets were identified and effective drugs were repurposed. The study demonstrated the usefulness and efficiency of the approach in improving drug repositioning for cancer treatment.

EBIOMEDICINE (2022)

添加到收藏夹

Article Oncology

A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma

Meng Yuan et al.

Summary: Computational drug repurposing is a promising strategy to discover potential indications of existing drugs. In this study, a systematic drug repositioning method based on comprehensive integration of molecular signatures in liver cancer tissue and cell lines was presented. Robust prognostic genes and gene co-expression modules enriched in unfavorable prognostic genes were identified, followed by the screening of potential target genes for HCC. A drug repositioning method was performed by integrating shRNA and drug perturbation data, leading to the identification of potential drugs for each target gene. The effects of the candidate drugs were evaluated through in vitro models, demonstrating the usefulness and efficiency of the network-based drug repositioning approach in discovering potential drugs for cancer treatment.

CANCERS (2022)

添加到收藏夹

Article Medicine, General & Internal

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning

Cheng Zhang et al.

Summary: This study investigated the effect of PKLR in an NAFLD model and identified two potential drug candidates through drug repositioning. These candidates showed significant inhibition of PKLR expression and triglyceride levels in in vitro models, and were also effective in reducing hepatic steatosis in in vivo rat models.

EBIOMEDICINE (2022)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma

Tingting Bian et al.

Summary: The mRNA and protein expression of TUBA1C is up-regulated in LUAD tissues, and its over-expression is associated with poor prognosis. TUBA1C is correlated with various tumor-infiltrating immune cells and is closely related to several important biological pathways in cancer.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Article Oncology

PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung

Torsten Goldmann et al.

Summary: The study reveals that PD-L1 amplification correlates with PD-L1 expression in squamous cell cancer and is associated with a tumor phenotype rich in immune cells. However, the correlation between PD-L1 amplification and PD-L1 protein expression is weak, and in some cases, PD-L1 protein may be negative despite amplification.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

添加到收藏夹

Article Cell Biology

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma

Min He et al.

Summary: Lower expression of CLEC10A in LUAD patients is associated with worse outcomes, and its expression is significantly correlated with various tumor-infiltrating immune cells. Therefore, CLEC10A may be a promising prognostic indicator and immunotherapy target for LUAD.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

添加到收藏夹

Article Respiratory System

A role for club cells in smoking-associated lung adenocarcinoma

Sabine J. Behrend et al.

Summary: The cellular origin of lung adenocarcinoma remains a focus of intense research efforts due to the marked cellular heterogeneity and molecular subtype diversity. Controversy exists regarding the tumor-initiating cells of lung adenocarcinoma, which may arise in distal pulmonary regions, affecting both smokers and nonsmokers, and influenced by environmental factors. Research on this topic includes studies in mouse models and human subjects, with a potential case for club cells as the origin of lung adenocarcinomas in smokers.

EUROPEAN RESPIRATORY REVIEW (2021)

添加到收藏夹

Article Oncology

Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis

Mingze Lu et al.

Summary: Six significantly downregulated DEGs were identified as prognostic markers and potential tumor suppressor genes in LAC using integrated bioinformatics methods. These genes could serve as potential therapeutic targets and molecular markers for LAC patients.

BMC CANCER (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype

Valentina Melocchi et al.

Summary: This research identified a specific subset of lung adenocarcinoma called C1-LUAD, characterized by aggressive behavior, stem cell-like characteristics, mutator and immune evasion phenotypes. Using a 10-gene prognostic signature, poor prognosis patients with this molecular subtype can be identified, suggesting potential alternative therapeutic strategies for early-stage aggressive LUAD.

ONCOGENE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

LINCS Data Portal 2.0: next generation access point for perturbation-response signatures

Vasileios Stathias et al.

NUCLEIC ACIDS RESEARCH (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer

Ok-Seon Kwon et al.

ONCOGENE (2020)

添加到收藏夹

Review Chemistry, Medicinal

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

Thanigaimalai Pillaiyar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma

Zhan-yu Xu et al.

PEERJ (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode

Zhou Jiawei et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

添加到收藏夹

Article Oncology

Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy

Lin Zheng et al.

MOLECULAR CANCER THERAPEUTICS (2019)

添加到收藏夹

Article Oncology

Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates

Marco Antonio De Bastiani et al.

CANCER MEDICINE (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment

A. B. Nagaraj et al.

ONCOGENE (2018)

添加到收藏夹

Article Oncology

Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients

Artur Mezheyeuski et al.

JOURNAL OF PATHOLOGY (2018)

添加到收藏夹

Review Medicine, General & Internal

Lung cancer: current therapies and new targeted treatments

Fred R. Hirsch et al.

LANCET (2017)

添加到收藏夹

Letter Genetics & Heredity

Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells

Robin M. Meyers et al.

NATURE GENETICS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

Aravind Subramanian et al.

CELL (2017)

添加到收藏夹

Review Chemistry, Medicinal

Mitoxantrone, More than Just Another Topoisomerase II Poison

Benny J. Evison et al.

MEDICINAL RESEARCH REVIEWS (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

Guangxu Jin et al.

DRUG DISCOVERY TODAY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Comprehensive molecular profiling of lung adenocarcinoma

Eric A. Collisson et al.

NATURE (2014)

添加到收藏夹

Article Chemistry, Medicinal

Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)

Sebastien Naud et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

添加到收藏夹

Article Biochemical Research Methods

NIH Image to ImageJ: 25 years of image analysis

Caroline A. Schneider et al.

NATURE METHODS (2012)

添加到收藏夹

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)

添加到收藏夹

Article Oncology

A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis

Humam Kadara et al.

CLINICAL CANCER RESEARCH (2011)

添加到收藏夹

Article Biochemical Research Methods

Drug-Induced Regulation of Target Expression

Murat Iskar et al.

PLOS COMPUTATIONAL BIOLOGY (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Decreased expression of the human immunoglobulin J-chain gene in squamous cell cancer and adenocarcinoma of the lungs

D. K. Slizhikova et al.

MOLECULAR BIOLOGY (2007)

添加到收藏夹

Article Oncology

Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis

Satoshi Hayama et al.

CANCER RESEARCH (2007)

添加到收藏夹

Article Multidisciplinary Sciences

The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease

Justin Lamb et al.

SCIENCE (2006)

添加到收藏夹

Article Surgery

Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo

AS Boehle et al.

LANGENBECKS ARCHIVES OF SURGERY (2002)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure-based design of potent CDK1 inhibitors derived from olomoucine

P Furet et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.